Back to search

Peptide record

TPDB40810

LPSBD-0 Anticancer standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB40810
LPSBD-0
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 21-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
CQYSVNPKIKRFELYFKGRMW
Physicochemical Analysis
C126H189N33O29S2
ADHT
K
2694.21
10.23
5
1
9
+4
0.94
-0.714
50.95
Mammalian: 1.2 hour Yeast: >20 hour E.coli: >10 hour
8480
314.75
6
Residue Composition
number
0
A
2
R
1
N
0
D
1
C
1
E
1
Q
1
G
0
H
1
I
1
L
3
K
1
M
2
F
1
P
1
S
0
T
1
W
2
Y
1
V
Amino Acid Distribution
A: 0 R: 2 N: 1 D: 0 C: 1 E: 1 Q: 1 G: 1 H: 0 I: 1 L: 1 K: 3 M: 1 F: 2 P: 1 S: 1 T: 0 W: 1 Y: 2 V: 1
Chemical Descriptors
21
C126H189N33O29S2
2694.21
10.23
+4
0.94
-0.714
Free
L
Linear
Free
Anticancer
Synthetic
Evidence Records 3 records
Evidence 1 Activity

Activity

~20% cell survival at 60 µg/ml
Anticancer

Target

Lung Cancer
A-549
Lung

Assay & Model

Cell Proliferation assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2015

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

~40% cell survival at 60 µg/ml
Anticancer

Target

Liver Cancer
Hep3B
Liver

Assay & Model

Cell Proliferation assay
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2015
Evidence 3 Activity

Activity

Not Available
Anticancer

Target

Leukemia Cancer
THP-1
Blood

Assay & Model

Not Available
24-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2019